AUPH EBITDA

Aurinia Pharmaceuticals Inc · EBITDA

AUPH logo

AUPH EBITDA

Latest reported$188.22M
AUPH TTM EBITDA (-$1.02M → $188.22M)
High-resolution chart · PNG

AUPH ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Aurinia Pharmaceuticals Inc EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
188,216,000
161,785,000
142,304,000
102,417,000
86,498,000
65,880,000
31,728,000
4,390,000
-23,005,000
-41,874,000
-63,047,000
-67,862,000
-68,601,000
-91,917,000
-103,646,000
-110,582,000
-152,837,000
-164,315,000
-177,660,000
-155,310,000
-147,800,000
-128,026,000
-102,745,000
-169,177,000
-145,820,000
-134,940,000
-122,115,000
-60,433,000
-59,753,000
-59,567,000
-62,625,000
-60,615,000
-56,109,000
-50,484,000
-45,608,000
-40,970,000
-32,570,000
-27,078,000
-21,335,000
-22,222,000
-23,188,000
-24,690,000
-25,408,000
-21,370,000
-19,153,000
-17,641,000
-15,807,000
-12,087,373
-11,326,373
-7,997,373
-5,332,373
-9,524,023
-7,981,226
-8,832,174
-8,392,722
-984,354
-388,090
6,439,118
5,128,112
448,932
167,045
-5,171,822
-4,312,850
-3,444,479
-3,879,876
-5,955,128
-7,750,280
-7,265,210
-9,128,383
-12,061,712
-14,417,103
-22,082,892
-26,403,414
-30,583,944
-32,442,581
-29,685,759
-28,107,016
-24,515,950
-22,332,257
-25,436,601
-25,699,966
-26,471,507
-28,891,694
-27,951,138
-27,693,497
-24,406,981
-20,495,913
-17,319,673
-14,936,038
-9,570,289
-9,530,923
-7,527,978
-1,854,849
-1,454,600
-736,885
-255,738
-5,290,023
-9,998,494
-10,234,034
-9,349,696
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.